Skip to main content
IBB logo
IBB
(NASDAQ)
iShares Biotechnology ETF
$213.56-- (--)
Loading... - Market loading

IBB ETF: iShares Biotechnology ETF - Price, Holdings & Analysis

iShares Biotechnology ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$211.06 - $215.61
52-Week High$202.00
52-Week Low$136.89
Open$211.55
Volume2.67M
Average Volume (3M)1.53M
Assets (AUM)9.47B
Expense Ratio0.44%
Total Holdings252
Inception DateFeb 5, 2001
1 Day Change1.85%
1 Month Change6.41%
6 Month Change15.37%
YTD Change19.49%
1 Year Change46.44%
52-Week Change45.52%
5 Year Change22.66%
10 Year Change108.67%
50-Day MA$186.89
200-Day MA$173.89
RSI68.04
Stochastic %K99.61
Stochastic %D87.96
Annual Dividend$0.41
Dividend Yield0.20%
Last Dividend Ex-DateSep 19, 2026
Dividend Growth YoY7.17%

Frequently Asked Questions About iShares Biotechnology ETF

What is the current price of IBB?

The latest IBB price is $213.56. The 52-week range is $136.89–$202.00. IBB has returned 45.5% over the past 52 weeks.

What is the expense ratio for IBB?

IBB's annual expense ratio is 0.44%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does IBB pay dividends?

Yes, IBB pays a 0.20% dividend yield. The last ex-dividend date was 2026-09-19. View full dividend history in the Dividends section.

What are the top holdings of IBB?

IBB's largest holdings are Amgen Inc. (8.3%), Vertex Pharmaceuticals Incorporated (7.9%), Gilead Sciences, Inc (7.1%) (combined weight: 23.3%). The fund holds 252 total positions. View the complete portfolio breakdown in the Holdings section.

How does IBB compare to similar ETFs?

Compare IBB (0.44% expense ratio, $9.47B AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.